MBX Biosciences (MBX) Other financing activities (2023 - 2026)

MBX Biosciences (MBX) has 4 years of Other financing activities data on file, last reported at $2.4 million in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities rose 60950.0% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (up 1018.35% YoY), and the FY2024 full-year result was $403000.0, down 45.47% from the prior year.
• Other financing activities rose to $2.4 million in Q1 2026, from -$1.3 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $174.3 million in Q3 2024 to a low of -$174.1 million in Q4 2024.
• A 4-year average of $318222.2 and a median of $50000.0 in 2024 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities sank 916621.05% in 2024 and surged 60950.0% in 2026, its largest moves.
• Tracing MBX's Other financing activities over 4 years: stood at $19000.0 in 2023, then slumped by 916621.05% to -$174.1 million in 2024, then soared by 99.24% to -$1.3 million in 2025, then surged by 283.61% to $2.4 million in 2026.
• Business Quant data shows MBX's Other financing activities at $2.4 million in Q1 2026, -$1.3 million in Q3 2025, and $1.3 million in Q2 2025.